Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint

Haisheng Yang1, Wanqiu Li2, Yingnan Lv1

  • 1School of Public Health, Guangxi Medical University, Nanning 530021, People's Republic of China; Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning 530021, People's Republic of China.

Gene
|September 7, 2019
PubMed

Insights

Investigating clear cell renal cell carcinoma (ccRCC) metastasis revealed key genes TF and B4GALNT1. These genes, linked to complement and cholesterol pathways, may serve as diagnostic markers and therapeutic targets for ccRCC.

Area of Science:

  • Urology
  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Clear cell renal cell carcinoma (ccRCC) is an aggressive urological cancer with unclear metastatic mechanisms.
  • Understanding ccRCC metastasis is crucial for improving patient survival rates.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying ccRCC metastasis.
  • To identify key genes and pathways involved in ccRCC progression and metastasis.

Main Methods:

  • Transcriptome analysis of ccRCC patients from The Cancer Genome Atlas (TCGA) database.
  • Differential gene expression analysis, KEGG and GO enrichment analyses.
  • Survival analysis and co-expression gene analysis to identify key metastatic genes.

Main Results:

  • Identified 323 differentially expressed genes (DEGs) between metastatic and non-metastatic ccRCC.
  • Enrichment analyses suggested roles for complement/coagulation cascades and cholesterol metabolism in ccRCC metastasis.
  • TF and B4GALNT1 were identified as key overexpressed genes associated with poor survival, potentially mediating metastasis through complement, focal adhesion, and signaling pathways.

Conclusions:

  • The complement system, coagulation cascade, cholesterol metabolism, calcium signaling, and iron transport are implicated in ccRCC metastasis.
  • TF and B4GALNT1 represent potential diagnostic markers and therapeutic targets for ccRCC, warranting further investigation.

Related Concept Videos

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Metastatic clear cell renal cell carcinoma is a disease without a comprehensive animal model for thorough preclinical investigation. This protocol illustrates two novel animal models for the disease: the orthotopically implanted mouse model and the chicken chorioallantoic membrane model, both of which demonstrate lung metastasis resembling clinical...
9.4K
Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

Models of spontaneous metastatic renal cell carcinoma (RCC) disease progression can be used for evaluating treatments in a clinically relevant setting. This protocol demonstrates different procedures for orthotopic kidney tumor cell implantation, proper nephrectomy, and finally outlines a necropsy guide for visual and bioluminescent scoring of metastatic burden and...
17.2K
Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

In vitro spheres assays are commonly used to identify cancer stem cells. Here we compare single with multi cell-based spheres assays. The more laborious single cell-based assays or methylcellulose supplementation give more accurate results while multi cell-based assays performed in liquid medium can be highly influenced by cell...
9.9K
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Implementation of an orthotopic model of renal cell carcinoma in immunocompetent mice affords the investigator a clinically-relevant system defined by the presence of a primary renal tumor and lung metastases in the same animal. This system can be used to preclinically test a variety of treatments in...
14.1K
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

The metastatic spread of cancer is the major cause of cancer-related deaths. We provide an in-depth description of our survival surgery methodology for establishing a “patient-like” orthotopic syngeneic mouse model system for studying the mechanisms of metastasis in solid organ...
12.8K
Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

A protocol is reported here for the selective ablation of renal macrophages to study their regeneration using the human CD59/intermedilysin cell ablation tool. This method is also applicable for studying the function and regeneration of the other cell populations in the kidney, liver, and fatty tissue.
677